Axis Capital (AXS) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the ...
Shares of AXIS Capital Holdings Limited AXS have gained 14.2% in the past year, outperforming its industry’s growth of 6.3%. The insurer has a market capitalization of $7.33 billion. The average ...
AXIS Capital Holdings AXS shares are trading at a discount to the Zacks Property and Casualty Insurance industry’s multiple of 1.65. Its price-to-book value of 1.36X is lower than the broader sector’s ...
Mizuho Securities analyst Graig Suvannavejh has maintained their bullish stance on AXSM stock, giving a Buy rating yesterday. Graig Suvannavejh has awarded Axsome Therapeutics a Buy rating based on a ...
Axsome Therapeutics shows strong revenue growth from Auvelity and Sunosi, with promising late-stage pipeline drugs for migraine, fibromyalgia, and narcolepsy. Late-stage pipeline milestones include ...
We recently compiled a list of the 12 Best Property & Casualty Insurance Stocks to Buy Now. In this article, we are going to take a look at where AXIS Capital Holdings Limited (NYSE:AXS) stands ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results